AstraZeneca Imfinzi plus chemotherapy recommended for marketing authorisation in EU for advanced biliary tract cancer Ruchika Sharma15 Nov 2022 5:44 PM ISTUK: AstraZeneca's Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adult...
AstraZeneca- Daiichi Sankyo Enhertu recommended for nod in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer Ruchika Sharma15 Nov 2022 12:15 PM ISTEnhertu is a HER2-directed ADC.
AstraZeneca tops quarterly estimates buoyed by cancer drug sales Ruchika Sharma13 Nov 2022 10:00 AM ISTDelaware: AstraZeneca on Thursday topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and...
AstraZeneca gets USFDA nod for Imfinzi, Imjudo with chemotherapy to treat metastatic non-small cell lung cancer Ruchika Sharma11 Nov 2022 2:30 PM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
AstraZeneca PT027 recommended by FDA advisory committee as new rescue treatment for asthma Ruchika Sharma9 Nov 2022 1:30 PM ISTAsthma is a chronic, inflammatory, variable respiratory disease that affects as many as 339 million people worldwide, including over 25 million in the...
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
AstraZeneca Asthma drug Fasenra fails one main goal in study of chronic immune disease Ruchika Sharma28 Oct 2022 1:30 PM ISTUK: High-level results from the MESSINA Phase III trial showed that AstraZeneca's Fasenra (benralizumab) did not meet one of the two dual-primary...
AstraZeneca Gets CDSCO panel nod to Import, Market Anti-Diabetic Dapagliflozin for Additional Indication Dr. Divya Colin23 Oct 2022 11:30 AM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Setback: AstraZeneca nasal spray COVID vaccine fails in early trial Ruchika Sharma11 Oct 2022 3:33 PM ISTThe immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.
AstraZeneca India, CAPED Trust launch 'Ganga Godavari Cancer Screening Program' in Mathura Ruchika Sharma5 Oct 2022 9:00 AM ISTFacilitated by Charities Aid Foundation (CAF) India, the primary aim of the program is to create cancer awareness, and detect oral, breast and...
AstraZeneca Rare Disease, Alexion to acquire LogicBio Therapeutics to accelerate growth in Genomic Medicine Ruchika Sharma4 Oct 2022 11:45 AM ISTAlexion, through a subsidiary, will initiate a cash tender offer to acquire all outstanding shares of LogicBio for $2.07 per share.
AstraZeneca severe asthma treatment Tezspire gets Japanese nod Ruchika Sharma28 Sept 2022 3:37 PM ISTUK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or...
